News

The clinical activity of neoadjuvant immunochemotherapy for treating locally advanced oral squamous cell carcinoma (LA-OSCC) remains uncertain. In this single-arm, phase II trial, the authors show ...
We are pleased to invite submissions for a forthcoming edited volume titled Accelerating Climate Action in Asia: Fiscal Policy Solutions. The edited book will contain a collection of chapters that aim ...
2 HCl solutions over seven weeks and no significant drift in potentials. The microsensor was determined to have optimum performance in the pH range of 4.0-8.0. The microsensor was successfully used to ...
Oral submucous fibrosis (OSF) is a serious disease that impairs mouth functionality, often leading to restricted opening and a high risk of malignant transformation. New research has uncovered a ...
LAKEWOOD, Colo. (KDVR) — Neighbors living in Lakewood are calling for the city to come up with a permanent solution to homeless encampments popping up in their neighborhoods. They say the sites ...
Inside a German military truck, soldiers guard a group of Jewish forced laborers en route to a grim task: The burial of the latest Jews gassed to death by the Nazis in a village in occupied Poland ...
Lockheed Martin has agreed to acquire Amentum’s Rapid Solutions business for approximately $360 million in cash. Amentum said Wednesday the transaction is expected to conclude in the second half ...
Ascletis is taking a low and slow approach to oral GLP-1 dose titration in a phase 2a test after getting a look at clinical data. The latest results show a high starting dose, fast titration model ...
SHANGHAI, April 23 (Reuters) - Mercedes-Benz (MBGn.DE), opens new tab CEO Ola Källenius said on Wednesday the German automaker was urging the European Union to find an "equitable solution" to ...
Treating a toothache with salt water can also help reduce inflammation and heal any oral wounds. To use this approach, mix 1/2 teaspoon (tsp) of salt into a glass of warm water and use it as a ...
Ascletis is hoping to initiate a Phase IIa trial in the US in Q3 2025. Image credit: Shutterstock / Pixel-Shot Ascletis has announced its oral glucagon-like peptide-1 receptor agonist (GLP-1RA) has ...
The Supreme Court has notably also heard oral arguments this past term in other religious liberty and gender-related suits. The high court heard oral arguments earlier this month in a suit brought ...